Showing 1 - 10 of 20
The purpose of this study was to estimate the risk and mortality of breast cancer recurrences in Swedish women, and to analyse changes over time and variations between patients in different risk groups. Such estimates are of key importance for modelling the cost-effectiveness of different...
Persistent link: https://www.econbiz.de/10010281338
The purpose of this study was to estimate the risk and mortality of breast cancer recurrences in Swedish women, and to analyse changes over time and variations between patients in different risk groups. Such estimates are of key importance for modelling the cost-effectiveness of different...
Persistent link: https://www.econbiz.de/10005423797
The purpose of this study was to estimate the risk and mortality of breast cancer recurrences in Swedish women, and to analyse changes over time and variations between patients in different risk groups. Such estimates are of key importance for modelling the cost-effectiveness of different...
Persistent link: https://www.econbiz.de/10003465814
We present three types of evidence about the effect of cancer drug vintage-year of initial world launch - on cancer survival and mortality. All three are based on group-level data, and employ difference-in-difference research designs, which enable us to control for the influence of potentially...
Persistent link: https://www.econbiz.de/10014049989
This report presents a computer model for evaluating the cost-effectiveness (CE) of Hormone Replacement Therapy (HRT). The model is an extension of a previous model and includes also the risk of spine and wrist fracture. New Swedish data on risk of coronary heart disease and related mortality...
Persistent link: https://www.econbiz.de/10014159659
Persistent link: https://www.econbiz.de/10013408659
The aim of medical innovations is to improve health. A medical innovation can be defined as the application of new medical knowledge, often but not always embodied in a product, for example a pharmaceutical drug. Improved medical knowledge is the product of investments in medical research and/or...
Persistent link: https://www.econbiz.de/10013018090
A purchaser/provider split together with output- based reimbursement were recently introduced by several Swedish county councils. These changes have been motivated by arguments of efficiency and consumer choice. This paper tests the null hypothesis that hospital services are provided as...
Persistent link: https://www.econbiz.de/10005423789
A separation of provider and purchaser roles - together with performance-based reimbursement - were recently introduced in several county councils, which are the local governments that provide and fund almost all health care in Sweden. These changes have been motivated by efficiency and consumer...
Persistent link: https://www.econbiz.de/10005649259
In a period where decentralisation seemed to be the prominent trend, Norway in 2002 chose to re-centralise the hospital sector. The reform had three main aims; cost control, efficiency and reduced waiting times. This study investigates whether the hospital reform has improved hospital...
Persistent link: https://www.econbiz.de/10005245177